Amylyx Pharmaceuticals, Inc. (AMLX) Price Target Analysis
Updated Jul 2, 2026
Analyst Rating: Buy
Based on 11 analysts74.3% Below Target
AMLX trades 74.3% below Wall Street's consensus target of $31.67.
Current Price$18.17
Average Target$31.67
Target
Current
Low$21.00
Median$34.00
High$40.00
Analyst Target Range
Forward P/E—
PEG Ratio—
Implied Growth-3.8%
(Declining)
Analyst Spread60.0%
(Moderate)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes AMLX achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 11 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
AMLX Price Target Analysis
Updated July 8, 2026As of July 8, 2026, Amylyx Pharmaceuticals, Inc. (AMLX) has a Wall Street consensus price target of $31.67, based on estimates from 11 covering analysts. With the stock currently trading at $18.17, this represents a potential upside of +74.3%. The company has a market capitalization of $1.51B.
Analyst price targets range from a low of $21.00 to a high of $40.00, representing a 60% spread in expectations. The median target of $34.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 10 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, AMLX trades at a trailing P/E of -11.9x. Analysts expect EPS to grow -3.8% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+39.0%
Industry Consensus
Avg Forward P/E
73.7x
(High Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 IONSIonis Pharmaceuticals, Inc. | $14.3B | $86.33 | $106.50 | +23.4% | Buy | — | 32 |
 BIIBBiogen Inc. | $30.4B | $205.70 | $218.32 | +6.1% | Buy | 14.2x | 48 |
 MDGLMadrigal Pharmaceuticals, Inc. | $12.6B | $545.36 | $656.00 | +20.3% | Buy | — | 23 |
 ACADACADIA Pharmaceuticals Inc. | $4.5B | $26.20 | $34.38 | +31.2% | Buy | 68.9x | 37 |
 PRTAProthena Corporation plc | $507M | $9.68 | $19.00 | +96.3% | Buy | 207.3x | 28 |
 AGENAgenus Inc. | $146M | $3.50 | $7.33 | +109.4% | Buy | 4.5x | 11 |
 ARVNArvinas, Inc. | $554M | $8.59 | $14.75 | +71.7% | Buy | — | 26 |
 SRRKScholar Rock Holding Corporation | $6.8B | $56.56 | $59.17 | +4.6% | Buy | — | 12 |
 ALKSAlkermes plc | $9.2B | $55.22 | $52.60 | -4.7% | Buy | — | 29 |
 RAREUltragenyx Pharmaceutical Inc. | $3.5B | $35.87 | $47.11 | +31.3% | Buy | — | 33 |
AMLX — Frequently Asked Questions
Quick answers to the most common questions about buying AMLX stock.
What is the AMLX stock price target for 2026?
The consensus Wall Street price target for AMLX is $31.67, representing 74.3% upside from the current price of $18.17. With 11 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is AMLX a buy, sell, or hold?
AMLX has a consensus rating of "Buy" based on 11 Wall Street analysts. The rating breakdown is predominantly bullish, with 10 Buy/Strong Buy ratings. The consensus 12-month price target of $31.67 implies 74.3% upside from current levels.
Is AMLX stock overvalued or undervalued?
AMLX's current price is $18.17 with a consensus target of $31.67 (74.3% implied move). Analyst estimates suggest the stock is undervalued at current levels.
How high can AMLX stock go?
The most bullish Wall Street analyst has a price target of $40 for AMLX, while the most conservative target is $21. The consensus of $31.67 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover AMLX stock?
AMLX is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 10 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the AMLX stock forecast?
The 12-month AMLX stock forecast based on 11 Wall Street analysts shows a consensus price target of $31.67, with estimates ranging from $21 (bear case) to $40 (bull case). The median consensus rating is "Buy".
Should I buy AMLX stock?
Wall Street analysts are very optimistic on AMLX, with a "Buy" consensus rating and $31.67 price target (74.3% upside). 10 of 11 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do AMLX price targets vary so much?
AMLX analyst price targets range from $21 to $40, a 60% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $31.67 consensus represents the middle ground.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare